New Generation mRNA Booster Vaccine Against Emerging VOCs

Clinical trial NCT05580159 · UNKNOWN

Trial details

NCT number: NCT05580159
Sponsor: Stemirna Therapeutics
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Immunogenicity Efficacy Safety

Start date: 2022-10-01
Primary completion: 2023-05-11
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.